Austrian Left Atrial Appendage Closure Registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03409159

Enrollment

200

Registered

2018-01-24

Start date

2017-05-16

Completion date

2025-12-31

Last updated

2024-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Left Atrial Appendage Closure

Brief summary

Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registry aims to document all LAAC procedures in Austria.

Interventions

DEVICELAAC

Left atrial appendage closure

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients who received LAAC in Austria

Exclusion criteria

* Absence of informed consent

Design outcomes

Primary

Measure	Time frame
Number of participants with successful left atrial appendage closure, as defined by European Society of Cardiology Guidelines	30 days

Secondary

Measure	Time frame
Number of participants with death, stroke or bleeding	5 years
Number of participants with procedure-related adverse events	30 days

Countries

Austria

Contacts

Primary ContactDaniel Scherr, Assoc.Prof. PD Dr.

daniel.scherr@medunigraz.at+4331638512544

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026